Prenatal Test Maker Faces Investor Suit Over False Positives

By Ryan Harroff (April 28, 2022, 6:21 PM EDT) -- Biotechnology and women's health company Natera got hit with a proposed shareholder class action after a series of stock drops followed revelations that Natera's prenatal test for genetic disorders allegedly gives inaccurate results for certain conditions....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!